She was diagnosed with alopecia areata, an autoimmune condition that disrupts regular hair growth, at just 18 months old and ...

So, we now have two FDA-approved JAK inhibitors for severe alopecia areata. Summer of 2022, we saw the approval of baricitinib, which is a JAK1/2 inhibitor for adults with severe alopecia areata.

Lilly and Incyte's already-marketed JAK inhibitor Olumiant (baricitinib) is currently in the lead among drugs for alopecia areata, with a filing due in the second half of this year after two ...

Pfizer said that Litfulo (ritlecitinib) is the first alopecia areata therapy to be cleared for use in adolescents in the EU. JAK1/2 inhibitor Olumiant (baricitinib) was the first drug to be ...

Researchers characterized a new entity of non-scarring alopecia, macular alopecia, which is defined by small lesions and spontaneous resolution.

Alopecia areata cases increased from 1990 to 2021, highlighting the need for further research into socioeconomic factors and ...

Adolescents with alopecia areata experience a greater effect on quality of life than adults when experiencing 50% or greater scalp hair loss.

He and others appreciated similarities in its appearance to "pelade," the French term for alopecia areata, hence the name pseudopelade. The following description of the pseudopelade of Brocq will ...

This exciting colloquium was spearheaded by the Cicatricial Alopecia Research Foundation (C.A.R.F.). In this article, clinical aspects of six of the more common types of primary cicatricial ...

2022 — Researchers have discovered that a signaling molecule called SCUBE3 potently stimulates hair growth and may offer a therapeutic treatment for androgenetic alopecia, a common form of hair ...

Disruption of such homeostasis leads to HF disorders, such as alopecia, pigment loss ... including JAK inhibitors and PGD inhibitors. Among which, baricitinib has recently been approved for the ...